Purified chick-embryo cell rabies vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, Mahidol University

Conditions

RabiesVirus Diseases

Phase 3

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

CompletedNCT02545517

GlaxoSmithKlineRabies, Virus Diseases

Start: 2015-10-05End: 2022-12-23Updated: 2024-07-18

Unknown Phase

Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients

CompletedNCT03093545

Mahidol UniversityRabies

Start: 2015-03-31End: 2016-11-30Updated: 2017-04-04

Related Papers

Long-term persistence and boostability of immune responses following different rabies pre-exposure prophylaxis priming schedules of a purified chick embryo cell rabies vaccine administered alone or concomitantly with a Japanese encephalitis vaccine

PLoS neglected tropical diseases2025-05-27

CONSORT checklist.

OPAL (Open@LaTrobe) (La Trobe University)2025-05-27

Inclusion and exclusion criteria.

OPAL (Open@LaTrobe) (La Trobe University)2025-05-27